ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $880,000 | +10.6% | 15,489 | -14.4% | 0.05% | +14.0% |
| Q2 2021 | $796,000 | -18.2% | 18,091 | -8.3% | 0.04% | -23.2% |
| Q1 2021 | $973,000 | +19.4% | 19,724 | +1.8% | 0.06% | -5.1% |
| Q4 2020 | $815,000 | -59.5% | 19,366 | -55.9% | 0.06% | -9.2% |
| Q3 2020 | $2,010,000 | -64.2% | 43,902 | -60.7% | 0.06% | -55.2% |
| Q2 2020 | $5,612,000 | -13.0% | 111,769 | -10.9% | 0.14% | -14.7% |
| Q1 2020 | $6,453,000 | -24.3% | 125,472 | -9.1% | 0.17% | +41.7% |
| Q4 2019 | $8,524,000 | +3757.0% | 137,980 | +3647.4% | 0.12% | +3900.0% |
| Q3 2019 | $221,000 | -57.0% | 3,682 | -39.6% | 0.00% | -70.0% |
| Q2 2019 | $514,000 | +18.2% | 6,095 | +33.8% | 0.01% | +11.1% |
| Q1 2019 | $435,000 | +75.4% | 4,556 | +30.1% | 0.01% | +80.0% |
| Q4 2018 | $248,000 | -38.0% | 3,502 | -25.1% | 0.01% | -37.5% |
| Q3 2018 | $400,000 | -91.8% | 4,677 | -88.9% | 0.01% | -93.5% |
| Q2 2018 | $4,869,000 | +1161.4% | 42,007 | +779.5% | 0.12% | +1027.3% |
| Q1 2018 | $386,000 | – | 4,776 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |